Xue-Ji Zhang

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Breast cancer is a leading killer of women worldwide. Cyclodextrin-based estrogen receptor-targeting drug-delivery systems represent a promising direction in cancer therapy but have rarely been investigated. To seek new targeting therapies for membrane estrogen receptor-positive breast cancer, an estrogen-anchored cyclodextrin encapsulating a doxorubicin(More)
  • 1